Therapy Clinical Trials

1,459 recruitingLast updated: July 17, 2026

There are 1,459 actively recruiting therapy clinical trials across 83 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Guangzhou, Guangdong, China, Beijing, Beijing Municipality, China, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


Therapy Trials at a Glance

1,459 actively recruiting trials for therapy are listed on ClinicalTrialsFinder across 6 cities in 83 countries. The largest study group is Not Applicable with 577 trials, with the heaviest enrollment activity in Guangzhou, Beijing, and Shanghai. Lead sponsors running therapy studies include Sun Yat-sen University, Fudan University, and Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

Treatments under study

About Therapy Clinical Trials

Looking for clinical trials for Therapy? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,459 trials

Recruiting
Phase 2

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm+1 more
National Cancer Institute (NCI)335 enrolled222 locationsNCT05554406
Recruiting

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

StrokeAcute Ischemic StrokeThrombolysis+2 more
Sigmund Freud PrivatUniversitat462 enrolled8 locationsNCT07299994
Recruiting
Not Applicable

Vaginal Dilator Therapy After Pelvic Radiation

vaginal stenosisGynecologic CancersUrologic Cancer+3 more
Duke University130 enrolled1 locationNCT07216456
Recruiting
Not Applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Skin CancerSquamous Cell CarcinomaBrachytherapy+3 more
Alpha Tau Medical LTD.28 enrolled11 locationsNCT06615635
Recruiting

The Better, Harder, Faster, Stronger Study

Ovarian CancerEndometrial CancerNeoadjuvant Chemotherapy+2 more
Wake Forest University Health Sciences35 enrolled1 locationNCT07220512
Recruiting
Phase 2

Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer

Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital70 enrolled1 locationNCT07704177
Recruiting
Phase 2

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

ObesityWeight LossEating+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)148 enrolled1 locationNCT00739362
Recruiting
Not Applicable

Cash Transfers to Pregnant Women With HIV

PregnancyHIVHIV Antiretroviral Therapy (ART) Adherence+1 more
University of Pennsylvania100 enrolled8 locationsNCT07226492
Recruiting
Not Applicable

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

CancerRadiation TherapyDietary intake
University of Minnesota20 enrolled1 locationNCT07682714
Recruiting
Phase 2

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Neoadjuvant Immunotherapy
Tianjin Medical University Second Hospital21 enrolled1 locationNCT05837806
Recruiting
Not Applicable

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy With Type 2 DiabetesPeripheral Neuropathies+2 more
RxFunction Inc.200 enrolled6 locationsNCT06959277
Recruiting

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell CarcinomaChemotherapy EffectDNA Methylation
City of Hope Medical Center150 enrolled1 locationNCT06490003
Recruiting
Not Applicable

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Metastatic SarcomaEwing SarcomaRhabdomyosarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins70 enrolled3 locationsNCT06796543
Recruiting
Phase 2

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more
National Cancer Institute (NCI)2,000 enrolled348 locationsNCT05564390
Recruiting
Not Applicable

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

InsomniaTraumatic Brain InjuryDepression+7 more
Johns Hopkins University360 enrolled5 locationsNCT05663034
Recruiting
Phase 3

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

Standard Quadruple Antiemetic TherapyElectroacupunctureChemotherapy-induced Gastrointestinal Symptom Cluster
Jiuda Zhao388 enrolled1 locationNCT06952920
Recruiting
Phase 2

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

Endocrine System DiseasesImmune System DiseasesAutoimmune Diseases+6 more
University of Washington60 enrolled2 locationsNCT07699380
Recruiting
Not Applicable

Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis

EndometriomaQuality of LifeUltrasound Therapy; Complications+1 more
Hospital Universitari de Bellvitge288 enrolled28 locationsNCT06955221
Recruiting
Phase 2

Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma (HNSCC)Neoadjuvant TherapyHead and Neck Squamous Cell Carcinoma+1 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine182 enrolled1 locationNCT07601737
Recruiting
Not Applicable

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy

Pathological Complete ResponseLocally Advanced Rectal CancerNeoadjuvant Chemoradiotherapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS179 enrolled1 locationNCT04815694